Ankit Goel

@metrocollege.in

Assistant Professor at Department of Pharmacy
Metro College of Health Sciences and Research

Ankit Goel


                           Download Compact PDF  
https://researchid.co/pharmacistankitgoel
I have completed B.Pharm and M.Pharm (Pharmaceutical Chemistry) from IFTM University, Moradabad. I have worked as a Chemist in Quality Assurance Department at Themis Medicare Ltd., Haridwar. At present, I am an Assistant Professor in Department of Pharmacy at Metro College of Health Sciences and Research, Greater Noida, UP, India. I have more than 3 years of strong academic, research and industrial experience.

EDUCATION

B.Pharm, M.Pharm (Pharmaceutical Chemistry), PhD (Pursuing)

RESEARCH, TEACHING, or OTHER INTERESTS

Pharmacy, Pharmaceutical Science
4

Scopus Publications

27

Scholar Citations

2

Scholar h-index

1

Scholar i10-index

Scopus Publications

  • Synthesis, characterization, computational studies and anti-inflammatory activity evaluation of some new indole substituted aryl ethers
    Arun K Mishra, Ankit Goel, Harpreet Singh, Arvind Kumar, Sarvesh K Paliwal, Gyas Khan, Neyaz Ahsan, Amrita Mishra
    Journal of Molecular Structure, 2025
  • Innovations in Drug Delivery Systems for Biologics: Enhancing Stability and Targeted Delivery for Next-Generation Therapeutics
    , Pushpendra Kumar, Ankit Goel, , Biswajit Dash, , Poonam Rishishwar, , Jailani S, , Meghraj Vivekanand Suryawanshi, , Sanjay Rishishwar, , Neethu Asokan, and
    Zhongguo Ying Yong Sheng Li Xue Za Zhi Zhongguo Yingyong Shenglixue Zazhi Chinese Journal of Applied Physiology, 2025
    The aim of this study is to explore and evaluate recent innovations in drug delivery systems (DDS) for biologics, focusing on enhancing stability and targeted delivery to improve the efficacy and safety of next-generation therapeutics. The most recent developments in a variety of DDS, such as nanoparticles, microneedles, hydrogels, and biodegradable polymers, were examined in depth. Information from peer-audited diaries, clinical preliminaries, and mechanical reports were blended to survey the presentation of these frameworks concerning dependability, designated conveyance, patient consistence, and controlled discharge. A radar chart was used in a comparative analysis to show the advantages and disadvantages of each DDS. Utilizing cutting-edge DDS, our analysis revealed significant improvements in the stability and targeted delivery of biologics. Nanoparticles exhibited the most elevated precision in designated conveyance at 92% and showed a 85% improvement in soundness. With an 88% satisfaction rate and moderate improvements in other criteria, microneedles achieved the highest level of patient compliance. Biodegradable polymers provided a balanced enhancement across all criteria, with 88% improvements in stability, 87% improvements in targeted delivery, and 89% improvements in controlled release for hydrogels. Nanoparticles lost only 6% of their stability, microneedles lost 10% of their controlled release, hydrogels lost 7% of their stability, and biodegradable polymers lost 5% of their patient compliance across all of these systems. The stability and precise delivery of biologics have been significantly improved by advancements in drug delivery systems. Hydrogels and microneedles, on the other hand, provide advantages in controlled release and patient compliance. Biodegradable polymers and nanoparticles are promising for maintaining drug integrity and targeting particular sites. In order to overcome the limitations that exist currently and enhance the therapeutic outcomes of biologics, future research ought to concentrate on hybrid strategies that combine the advantages of multiple DDS.
  • Harnessing Pharmacogenomics for Personalized Medicine: Tailoring Drug Therapy to Genetic Profiles
    , Pushpendra Kumar, Ankit Goel, , Pooja Malik, , Surbhi Sirswal, , Poonam Rishishwar, , Sanjay Rishishwar, and
    Zhongguo Ying Yong Sheng Li Xue Za Zhi Zhongguo Yingyong Shenglixue Zazhi Chinese Journal of Applied Physiology, 2024
    This study means to investigate the capability of pharmacogenetics which can customize drug treatment through altered treatment of male genetic profiles. We finished hereditary profiling utilizing cutting edge sequencing (NGS) to figure out the key hereditary varieties that impact the medications metabolic adequacy and security. Patients were checked for a very long time to evaluate clinical results including ADRs and general wellness. Hereditary assessment uncovered variations in enormous qualities, for example, CYP2C9 CYP2D6 ABCB1 VKORC1 and SLCO1B1 which assume significant parts in drug digestion and transport. These hereditary markers are related with clinical realities to evaluate their effect on drug reactions and unfriendly impacts. The outcomes recommend that customized treatment dependent exclusively upon hereditary profiles could prompt better treatment results. For instance, patients with VKORC1 changes answer better to anticoagulants and drain less while patients with SLCO1B1 transformations have statin-incited myopathy which is more expensive and requires portion changes. This mirrors the useful effect of altered treatment on wellness results. Pharmacogenomics gives a useful asset to customized medication to tailor drug medicines dependent exclusively upon a person's genetic profile.
  • A Comprehensive Review: Pharmacogenomics and Personalized Medicine Customizing Drug Therapy Based on Individual Genetics Profiles
    , Biswajit Dash, Murshidha Shireen, , Mr. Pushpendra, , Shivam Kumar, , Ankit Goel, , Preeti Semwal, , Rekha Rani, and
    Zhongguo Ying Yong Sheng Li Xue Za Zhi Zhongguo Yingyong Shenglixue Zazhi Chinese Journal of Applied Physiology, 2024
    Numerous factors, such as genetics, environmental factors, and illness determinants, might contribute to an unpleasant pharmaceutical response. In an effort to increase efficacy and safety, as well as to gain a better understanding of drug disposition and clinical consequences, researchers in the two quickly emerging fields of pharmacogenetics (which focuses on single genes) and pharmacogenomics (which focuses on many genes) have studied the genetic personalization of drug response. This is due to the fact that a large number of pharmacological responses seem to be genetically based, and the relationship between medication response and genotype may be important for diagnosis. We now have a better understanding of the genetic basis of individual medication responses because to research on pharmaceuticals and genes. Pharmacogenomics aims to improve patient outcomes by developing personalized medicine by using the diversity of the human genome and how it affects medication response. Translational in nature, pharmacogenomics research encompasses everything from the discovery of genotype-phenotype associations to clinical investigations that might show therapeutic relevance. Though the conversion of pharmacogenomics research findings into clinical practice has been sluggish, advances in the field offer considerable potential for future therapeutic applications in specific people.

RECENT SCHOLAR PUBLICATIONS

  • Pyrazoline as a Promising Scaffold for Antiepileptic Drug Development: A Comprehensive Review
    R Sharma, A Goel, R Kaushik, K Yadav, H Fatima, R Chauhan, ...
    2025
  • Synthesis, characterization, computational studies and anti-inflammatory activity evaluation of some new indole substituted aryl ethers
    AK Mishra, A Goel, H Singh, A Kumar, SK Paliwal, G Khan, N Ahsan, ...
    Journal of Molecular Structure 1322, 140290 , 2025
    2025
    Citations: 2
  • Innovations in drug delivery systems for biologics: enhancing stability and targeted delivery for next-generation therapeutics
    S Rishishwar, N Asokan
    Chin. J. Appl. Physiol 41, e20250001 , 2025
    2025
    Citations: 7
  • Harnessing Pharmacogenomics for Personalized Medicine: Tailoring Drug Therapy to Genetic Profiles
    P Kumar, A Goel, P Malik, S Sirswal, P Rishishwar, S Rishishwar
    Chinese Journal of Applied Physiology, e20240035 , 2024
    2024
  • Assessment of prescribing pattern among type-ii diabetes mellitus patients in a tertiary care hospital
    S Saklani, A Goel, P Rishishwar, S Rishishwar
    World J. Pharm. Res. 13 (17), 750-766 , 2024
    2024
    Citations: 2
  • A comprehensive review: pharmacogenomics and personalized medicine customizing drug therapy based on individual genetics profiles
    B Dash, M Shireen, S Kumar, A Goel, P Semwal, R Rani
    Zhongguo Ying Yong Sheng Li Xue Za Zhi 40, e20240011 , 2024
    2024
    Citations: 16
  • ASSESSMENT OF PRESCRIPTION PATTERNS OF DRUGS USED IN COPD PATIENTS IN A TERTIARY CARE HOSPITAL
    S Saklani, Y Joshi, A Goel, P Rishishwar
    World 3 (4), 225-237 , 2024
    2024

MOST CITED SCHOLAR PUBLICATIONS

  • A comprehensive review: pharmacogenomics and personalized medicine customizing drug therapy based on individual genetics profiles
    B Dash, M Shireen, S Kumar, A Goel, P Semwal, R Rani
    Zhongguo Ying Yong Sheng Li Xue Za Zhi 40, e20240011 , 2024
    2024
    Citations: 16
  • Innovations in drug delivery systems for biologics: enhancing stability and targeted delivery for next-generation therapeutics
    S Rishishwar, N Asokan
    Chin. J. Appl. Physiol 41, e20250001 , 2025
    2025
    Citations: 7
  • Synthesis, characterization, computational studies and anti-inflammatory activity evaluation of some new indole substituted aryl ethers
    AK Mishra, A Goel, H Singh, A Kumar, SK Paliwal, G Khan, N Ahsan, ...
    Journal of Molecular Structure 1322, 140290 , 2025
    2025
    Citations: 2
  • Assessment of prescribing pattern among type-ii diabetes mellitus patients in a tertiary care hospital
    S Saklani, A Goel, P Rishishwar, S Rishishwar
    World J. Pharm. Res. 13 (17), 750-766 , 2024
    2024
    Citations: 2
  • Pyrazoline as a Promising Scaffold for Antiepileptic Drug Development: A Comprehensive Review
    R Sharma, A Goel, R Kaushik, K Yadav, H Fatima, R Chauhan, ...
    2025
  • Harnessing Pharmacogenomics for Personalized Medicine: Tailoring Drug Therapy to Genetic Profiles
    P Kumar, A Goel, P Malik, S Sirswal, P Rishishwar, S Rishishwar
    Chinese Journal of Applied Physiology, e20240035 , 2024
    2024
  • ASSESSMENT OF PRESCRIPTION PATTERNS OF DRUGS USED IN COPD PATIENTS IN A TERTIARY CARE HOSPITAL
    S Saklani, Y Joshi, A Goel, P Rishishwar
    World 3 (4), 225-237 , 2024
    2024